Nuria Gendrau

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial

Coleman, R; Hall, A; Albanell, J; Hanby, A; Bell, R; Cameron, D; Dodwell, D; Marshall, H; Jean-Mairet, J; Tercero, JC; Rojo, F; Gregory, W; Gomis, RR

Lancet Oncology

18

(11 )

1543 -

1552

(2017)

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth

Slebe, F; Rojo, F; Vinaixa, M; García-Rocha, M; Testoni, G; Guiu, M; Planet, E; Samino, S; Arenas, EJ; Beltran, A; Rovira, A; Lluch, A; Salvatella, X; Yanes, O; Albanell, J; Guinovart, JJ; Gomis, RR

Nature Communications

7

(- )

11199 -

-

(2016)

Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis

Pavlovic, M; Arnal-Estapé, A; Rojo, F; Bellmunt, A; Tarragona, M; Guiu, M; Planet, E; Garcia-Albéniz, X; Morales, M; Urosevic, J; Gawrzak, S; Rovira, A; Prat, A; Nonell, L; Lluch, A; Jean-Mairet, J; Coleman, R; Albanell, J; Gomis, RR

Jnci-Journal Of The National Cancer Institute

107

(12 )

djv256 -

djv256

(2015)

ERK1/2 Signaling Induces Upregulation of ANGPT2 and CXCR4 to Mediate Liver Metastasis in Colon Cancer

Urosevic, J; Blasco, MT; Llorente, A; Bellmunt, A; Berenguer-Llergo, A; Guiu, M; Cañellas, A; Fernandez, E; Burkov, I; Clapés, M; Cartanà, M; Figueras-Puig, C; Batlle, E; Nebreda, AR; Gomis, RR

Cancer Research

80

(21 )

4668 -

4680

(2020)

MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+breast cancer

Gawrzak, S; Rinaldi, L; Gregorio, S; Arenas, EJ; Salvador, F; Urosevic, J; Figueras-Puig, C; Rojo, F; Barrantes, ID; Cejalvo, JM; Palafox, M; Guiu, M; Berenguer-Llergo, A; Symeonidi, A; Bellmunt, A; Kalafatovic, D; Arnal-Estapé, A; Fernández, E; Müllauer, B; Groeneveld, R; Slobodnyuk, K; Attolini, CSO; Saura, C; Arribas, J; Cortes, J; Rovira,...

Nature Cell Biology

20

(2 )

211 -

+

(2018)

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial

Coleman, R; Hall, A; Albanell, J; Hanby, A; Bell, R; Cameron, D; Dodwell, D; Marshall, H; Jean-Mairet, J; Tercero, JC; Rojo, F; Gregory, W; Gomis, RR

Lancet Oncology

18

(11 )

1543 -

1552

(2017)

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth

Slebe, F; Rojo, F; Vinaixa, M; García-Rocha, M; Testoni, G; Guiu, M; Planet, E; Samino, S; Arenas, EJ; Beltran, A; Rovira, A; Lluch, A; Salvatella, X; Yanes, O; Albanell, J; Guinovart, JJ; Gomis, RR

Nature Communications

7

(- )

11199 -

-

(2016)

Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis

Pavlovic, M; Arnal-Estapé, A; Rojo, F; Bellmunt, A; Tarragona, M; Guiu, M; Planet, E; Garcia-Albéniz, X; Morales, M; Urosevic, J; Gawrzak, S; Rovira, A; Prat, A; Nonell, L; Lluch, A; Jean-Mairet, J; Coleman, R; Albanell, J; Gomis, RR

Jnci-Journal Of The National Cancer Institute

107

(12 )

djv256 -

djv256

(2015)

ERK1/2 Signaling Induces Upregulation of ANGPT2 and CXCR4 to Mediate Liver Metastasis in Colon Cancer

Urosevic, J; Blasco, MT; Llorente, A; Bellmunt, A; Berenguer-Llergo, A; Guiu, M; Cañellas, A; Fernandez, E; Burkov, I; Clapés, M; Cartanà, M; Figueras-Puig, C; Batlle, E; Nebreda, AR; Gomis, RR

Cancer Research

80

(21 )

4668 -

4680

(2020)

MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+breast cancer

Gawrzak, S; Rinaldi, L; Gregorio, S; Arenas, EJ; Salvador, F; Urosevic, J; Figueras-Puig, C; Rojo, F; Barrantes, ID; Cejalvo, JM; Palafox, M; Guiu, M; Berenguer-Llergo, A; Symeonidi, A; Bellmunt, A; Kalafatovic, D; Arnal-Estapé, A; Fernández, E; Müllauer, B; Groeneveld, R; Slobodnyuk, K; Attolini, CSO; Saura, C; Arribas, J; Cortes, J; Rovira,...

Nature Cell Biology

20

(2 )

211 -

+

(2018)

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial

Coleman, R; Hall, A; Albanell, J; Hanby, A; Bell, R; Cameron, D; Dodwell, D; Marshall, H; Jean-Mairet, J; Tercero, JC; Rojo, F; Gregory, W; Gomis, RR

Lancet Oncology

18

(11 )

1543 -